CD8A and neoplasm: We have recently shown that SCFAs are also capable of promoting the cytotoxic phenotype of tumor-specific CD8+ T cells and chimeric antigen receptor (CAR) T cells, thereby enhancing their anti-tumor activity (Luu et al., 2021).